-
oa Erratum
- Source: Letters in Drug Design & Discovery, Volume 3, Issue 5, Jul 2006, p. 356 - 356
-
- 01 Jul 2006
Abstract
In the article entitled "Pyrazinobenzodiazepines as Potent Nonpeptide Vasopressin Receptor Antagonists" by Jay M. Matthews et al. (Letters in Drug Design & Discovery, 2005, Vol. 2(3), 219-223) the authors report that for the Page 222, column 1, paragraph 3, line 9: The reduction of urine osmolality should be 77% (not 23%). Page 222, column 2, line 3: The alteration of urine osmolality should be -81% (not -19%).
© Bentham Science Publishers